Activation of the ras/raf-1 signal transduction pathway in carcinoid tumor cells results in morphologic transdifferentiation

This publication has 20 references indexed in Scilit:

• An analysis of 8305 cases of carcinoid tumors
  Cancer, 2000
• Raf-1 Causes Growth Suppression and Alteration of Neuroendocrine Markers in DMS53 Human Small-Cell Lung Cancer Cells
  American Journal of Respiratory Cell and Molecular Biology, 1999
• Review article: current status of gastrointestinal carcinoids
  Alimentary Pharmacology & Therapeutics, 1999
• Therapeutic Alternatives in Metastatic Neuroendocrine Tumors
  Surgical Oncology Clinics of North America, 1998
• Post-transcriptional silencing of RET occurs, but is not required, during raf-1 mediated differentiation of medullary thyroid carcinoma cells
  Oncogene, 1998
• Isolated Liver Metastases from Neuroendocrine Tumors: Does Resection Prolong Survival?
  Journal of the American College of Surgeons, 1998
• Raf-Induced Proliferation or Cell Cycle Arrest Is Determined by the Level of Raf Activity with Arrest Mediated by p21^Cip1
  Molecular and Cellular Biology, 1997
• Differentiation of medullary thyroid cancer by C-Raf-1 silences expression of the neural transcription factor human achaete-scute homolog-1
  Surgery, 1996
• The cytoplasmic raf oncogene induces a neuronal phenotype in PC12 cells: a potential role for cellular raf kinases in neuronal growth factor signal transduction.
  Proceedings of the National Academy of Sciences, 1993
• Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells.
  Proceedings of the National Academy of Sciences, 1987